Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post-COVID-19 ConditionsArticle Published on 2022-11-012022-11-16 Journal: JAMA Psychiatry [Category] SARS, 유전자 메커니즘, [키워드] 95% CI adjusted age Anxiety baseline characterized Comorbidities condition COVID COVID-19 COVID-19 symptom COVID-19-related symptom Depression determine distress female Final Follow-up Future Health health care workers highest impairment increased risk individual Infection loneliness long-lasting lowest mechanism Nurse outcome pandemic participant Participants Perceived Perceived stress positive Postinfection prospective cohort study Psychological distress questionnaire Questionnaires reported returned risk risk factor SARS-COV-2 infection SARS-CoV-2 test sociodemographic factors Symptoms the mean these symptom used data were measured Worry [DOI] 10.1001/jamapsychiatry.2022.2640 PMC 바로가기
Estimation of R0 for the spread of SARS-CoV-2 in Germany from excess mortalityArticle Published on 2022-10-142022-11-16 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI calculated can be used contagious dataset death deaths determine early phase Effect estimate estimation Europe Germany growth growth factor incidence Infection lockdown measure Mortality much higher much lower office pandemic performed Robert Koch RT-PCR RT-PCR test RT-PCR testing SARS-CoV-2 Spread subject thought used data variant yielding [DOI] 10.1038/s41598-022-22101-7 PMC 바로가기
Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational studyArticle Published on 2022-10-082022-11-15 Journal: Lancet (London, England) [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] Abstract Admission age ambulatory patient Analysis Antiviral antiviral drug authority B.1.1.529 Case-control Charlson Comorbidity Index China Chinese clinical effectiveness Cohort Community Control COVID-19 outpatient Cox regression death Diagnosis diagnosis of SARS-CoV-2 Disease progression dominant Effectiveness glomerular filtration rate hazard Hong Kong hospitalisation HRs identify in both group In-hospital In-hospital death Infection intensive care Invasive mechanical ventilation less Logistic regression lower risk material median molnupiravir Mortality Nirmatrelvir non-hospitalised Odds ratio Older older patients outcome Outpatient Patient patients with COVID-19 primary analysis reduced risk Region Registered retrospective cohort risk Ritonavir SARS-CoV-2 SARS-COV-2 infection sensitivity analysis Sex supported the SARS-CoV-2 translation used data vaccination variant [DOI] 10.1016/S0140-6736(22)01586-0 PMC 바로가기
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 VaccinationArticle Published on 2022-10-012022-11-15 Journal: Annals of neurology [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI 95% confidence interval adenovirus-based adjusted adjusted odds ratio administration adverse effect analyzed ANN Anticoagulant Anticoagulants association autoimmune pathogenesis avoidance caused cerebral country COVID-19 diagnosed evaluate had no heparin hospital immune immunomodulation International Intravenous immunoglobulin lower mortality Mortality Patient Platelet recommendation reducing mortality SARS-CoV-2 SARS-CoV-2 vaccination significantly statistically significant the patient thrombotic treated Treatment used data Vaccines Venous thrombosis [DOI] 10.1002/ana.26431 PMC 바로가기
Respiratory virus circulation in children after relaxation of COVID-19 restrictions in fall 2021-A nationwide register study in Finland2021년 가을에 COVID-19 제한이 완화된 후 어린이의 호흡기 바이러스 순환-핀란드의 전국 등록 연구Article Published on 2022-09-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adenovirus Atypical calculated children circulation coronavirus COVID-19 ending epidemic peak Finnish highlight incidence increase in Infectious disease Influenza influenza A Non-COVID-19 Older other respiratory virus pandemic parainfluenza pathogen peaked pediatric respiratory respiratory syncytial virus respiratory virus respiratory viruses rhinovirus RSV School severe acute respiratory syndrome Coronavirus spring stratified Surveillance used data virus [DOI] 10.1002/jmv.27857 PMC 바로가기 [Article Type] Article
COVID-19 mRNA vaccine effectiveness against hospitalisation and death in veterans according to frailty status during the SARS-CoV-2 delta (B.1.617.2) variant surge in the USA: a retrospective cohort studyResearch article Published on 2022-09-012022-10-05 Journal: The Lancet. Healthy longevity [Category] SARS, 변종, 임상, [키워드] 95% CI Affair age Antigen assessment B.1.617.2 baseline category Cemetery center clinical COVID-19 COVID-19 vaccination COVID-19 vaccine death Department diagnosed education effective Effectiveness finding frailty funding Future hazard ratio hospitalisation information males medical condition Miami mRNA vaccine Odds ratio Older Patient populations positive Positive test preventing infection Primary outcome recruit reduced retrieved retrospective cohort study robust RT-PCR SARS-CoV-2 SARS-CoV-2 test shown Sociodemographic characteristics System tested the SARS-CoV-2 the vaccine used data vaccination Vaccine variant variant of SARS-CoV-2 veteran White people [DOI] 10.1016/S2666-7568(22)00166-0 [Article Type] Research article
Social Vulnerability and Rurality Associated With Higher Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection-Induced Seroprevalence: A Nationwide Blood Donor Study-United States, July 2020-June 2021더 높은 중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2) 감염 유발 혈청 유병률과 관련된 사회적 취약성과 농촌: 전국 헌혈자 연구-미국, 2020년 7월-2021년 6월Article Published on 2022-08-242022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 진단, [키워드] acute respiratory syndrome antibody association black Blood Care coronavirus coronavirus 2 coronavirus disease covariates COVID-19 cross-sectional deaths demographics demonstrated effort Health health equity Hispanic index Infection MOST Outbreaks pandemic quantified reduce regression models repeated reported respiratory rural rurality SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 seroprevalence Seroprevalence significantly Social vulnerability study period the United State used data Vaccination strategy vulnerability Washington [DOI] 10.1093/cid/ciac105 PMC 바로가기 [Article Type] Article
Developing a Long COVID Phenotype for Postacute COVID-19 in a National Primary Care Sentinel Cohort: Observational Retrospective Database AnalysisObservational Study Published on 2022-08-112022-10-04 Journal: JMIR Public Health and Surveillance [Category] 임상, [키워드] 95% CI acute COVID-19 acute infection addition biomedical ontologies BioPortal Clinical characteristics clinical symptom clinically coded coding college Comorbidities complex computerized contribute COVID COVID-19 data accuracy data extracts data sets database develop Developing diagnosed Diagnosis Digital tool disease disease management Electronic health record English Epidemiology Ethnicity general practitioner General practitioners groups had no Health Hospital admission Hospitalization Hospitalized include individual Infection Laboratory Logistic regression Long Long COVID long-COVID management medical record systems nomenclature office ontological Ontology Oxford Patient phenotype postacute COVID-19 syndrome primary care problems public health RCGP recorded recruited Research retrospective RSC SARS-CoV-2 sentinel social class Sociodemographic Study protocol Surveillance Symptom Systematized Nomenclature of Medicine used data Validity [DOI] 10.2196/36989 PMC 바로가기 [Article Type] Observational Study
Effectiveness of REGEN-COV antibody combination in preventing severe COVID-19 outcomes심각한 COVID-19 결과를 예방하는 REGEN-COV 항체 조합의 효과Article Published on 2022-08-022022-09-11 Journal: Nature Communications [Category] SARS, 변종, 임상, 진단, 치료법, [키워드] 95% CI antibody combination approved Casirivimab Clinical characteristics Combination COVID-19 COVID-19 hospitalization COVID-19 patients death defined delta variant demographic demographic and clinical characteristics determine Diagnosis effective Effectiveness Estimated FIVE hazard ratio healthcare high-risk patient High-risk patients Hospitalization Imdevimab infected with SARS-CoV-2 monoclonal antibodies monoclonal antibody outcome Patient performed reducing REGEN-COV Repository retrospective cohort study risk severe COVID-19 severe disease treated Treatment Treatment effectiveness used data were used [DOI] 10.1038/s41467-022-32253-9 PMC 바로가기 [Article Type] Article
Geographic, Occupational, and Sociodemographic Variations in Uptake of COVID-19 Booster Doses Among Fully Vaccinated US Adults, December 1, 2021, to January 10, 2022Article Published on 2022-08-012022-11-16 Journal: JAMA Network Open [Category] 변종, [키워드] 95% CI Adults age Analysis Asian booster dose Booster vaccine calculated Care census children conducted Coverage COVID-19 COVID-19 vaccine COVID-19 vaccines cross-sectional survey defined diagnosis of COVID-19 dose effort enrolled estimate female Geographic Health highest hospital household Immunity IMPROVE individual janssen less likelihood Medicaid Medicare multivariable National occupational Older outcome percentages pharmacies Poisson regression model Population Prevalence prevalence ratio proportion receipt receiving reported selected Social service Sociodemographic subgroups survey uptake used data Vaccine variants Variation Vermont waning immunity [DOI] 10.1001/jamanetworkopen.2022.27680 PMC 바로가기